Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

X-BIOTIX THERAPEUTICS, INC.

Filed by INNOVATIVE FEDERAL STRATEGIES, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 16, 2025
Income
$10,000.00
Expenses
Not reported
Filing UUID
9f3c4a38-7dff-4fb7-bd50-fba5eb4089ff
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

H.R.____/S.____, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Title II, all provisions related to Antimicrobial Resistance.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.